Business Description
![Genocea Biosciences Inc Genocea Biosciences Inc logo](https://static.gurufocus.com/logos/0C0000AJO3.png?14)
Genocea Biosciences Inc
NAICS : 325412
SIC : 2834
ISIN : US3724271040
Description
Genocea Biosciences Inc is a USA-based biopharmaceutical company discovering and developing novel cancer immunotherapies using its proprietary ATLAS platform. The ATLAS platform can profile each patient's CD4+ and CD8+ T cell immune responses to every potential target or antigen identified by next-generation sequencing of that patient's tumor. ATLAS zeroes in on both antigens that activate anti-tumor T cell responses and inhibitory antigens, or Inhibigens , that drive pro-tumor immune responses.
Financial Strength
Name | Current | Vs Industry | Vs History |
---|
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History |
---|
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
FCF Margin % | -2685.82 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-Forward-EBIT | -0.94 | |||||
EV-to-Forward-EBITDA | -0.94 | |||||
FCF Yield % | -292.78 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:GNCAQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Genocea Biosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 1.911 | ||
EPS (TTM) ($) | -0.66 | ||
Beta | 42.4 | ||
Volatility % | 149.42 | ||
14-Day RSI | 0 | ||
14-Day ATR ($) | 0.000007 | ||
20-Day SMA ($) | 0.0001 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 0.0001 - 0.0002 | ||
Shares Outstanding (Mil) | 58.78 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 0 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Genocea Biosciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Genocea Biosciences Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Genocea Biosciences Inc Frequently Asked Questions
What is Genocea Biosciences Inc(GNCAQ)'s stock price today?
The current price of GNCAQ is $0.00. The 52 week high of GNCAQ is $0.00 and 52 week low is $0.00.
When is next earnings date of Genocea Biosciences Inc(GNCAQ)?
The next earnings date of Genocea Biosciences Inc(GNCAQ) is 2024-08-30 Est..
Does Genocea Biosciences Inc(GNCAQ) pay dividends? If so, how much?
Genocea Biosciences Inc(GNCAQ) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |